Providence Saint Joseph Medical Center - Video Presentation
 
 
My Online CME Login Username: Password: Register >
Login Help >
 
 
Antimicrobial Stewardship: Why the Hospital and SNF should care

TUESDAY, January 22, 2019
12:15pm – Hope Conference Center
ANTIMICROBIAL STEWARDSHIP AFTER HOSPITAL DISCHARGE; WHY THE HOSPITAL AND SKILLED NURSING FACILITY SHOULD CARE
JAMES A. MCKINNELL, M.D.
ASSISTANT PROFESSOR OF MEDICINE, DAVID GEFFEN SCHOOL OF MEDICINE AT UCLA
MODERATOR:
Aric Gregson, MD, infectious disease specialist, PSJMC
FACULTY/PLANNER DISCLOSURES:
It is our policy to ensure that planners, faculty and content are independent of commercial bias. Dr. McKinnell states he is a research consultant for Achaogen, Melinta, Cempra, Thermo Fisher and Allergan; is on the Speakers Bureau for Allergan; and is the founder of Expert Stewardship. It is our policy to review presentations ahead of time in order to resolve any potential conflicts of interest. No conflicts were identified in the review of today’s presentation.
Disclosures for members of the Medical Education Committee may be found at the CME sign-in desk and on the CME website at
www.providencecme.org.
Click Here For Learning Objectives
Release Date: 4-17-19
Review Date: 4/22
Termination Date:

This activity is designated for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM.
1/22/2019
James McKinnell, MD.
Presenter
Hope Conference Center
Video List
The Path to Personalized Medicine in IBD
TUESDAY, April 9, 2019
12:15pm--Hope Conference Center
THE PATH TO PERSONALIZED MEDICINE IN IBD
DERMOT P.B. MCGOVERN, MD, PHD, MRCP
DIRECTOR, TRANSLATIONAL MEDICINE
F. WIDJAJA FOUNDATION INFLAMMATORY BOWEL AND IMMUNOBIOLOGY RESEARCH
INSTITUTE, CEDARS-SINAI MEDICAL CENTER
PLANNER/MODERATOR:
Ora Gordon, MD, MS; Regional Medical Director, Center for Clinical Genetics & Genomics; Medical Director, Integrative Medicine, Roy and Patricia Disney Family Cancer Center, PSJMC
FACULTY/PLANNER DISCLOSURES:
It is our policy to ensure that planners, faculty and content are independent of commercial bias. Dr. Gordon states she has no financial arrangements with any commercial company to disclose. Dr. McGovern discloses he is a consultant for Precision IBD, Gilead, Janssen, Bridge Therapeutics, Qu Biologics, and Pfizer, and has received grant support from Janssen and Second Genome. It is our policy to review presentations ahead of time in order to resolve any potential conflicts of interest. No conflicts were identified in the review of today’s presentation.
Disclosures for members of the Medical Education Committee may be found at the CME sign-in desk and on the CME website at
www.providencecme.org.
Click Here For Learning Objectives
Release Date: 5-15-19
Review Date: 5/22
Termination Date:

This activity is designated for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM.
04/09/2019
Dermot McGovern, MD.
Presenter
Hope Conference Center
Arthritis
THURSDAY, March 21, 2019
12:15pm, Hope Conference Center
ORTHOPEDIC OPTIONS FOR PATIENTS WITH ARTHRITIS
SHAHAB MAHBOUBIAN, DO
DEPARTMENT OF SURGERY, PSJMC
PLANNER/MODERATOR:
Nilesh Desai, MD, Department of Medicine liaison to the Medical Education Committee, PSJMC
FACULTY/PLANNER DISCLOSURES:
It is our policy to ensure that planners, faculty and content are independent of commercial bias. Drs. Desai and Mahboubian state they have no financial relationship with a commercial company to disclose.
Disclosures for members of the Medical Education Committee may be found at the CME sign-in desk and on the CME website at
www.providencecme.org.
Click Here For Learning Objectives

This activity satisfies DHS radiology requirements for renewal of fluoroscopy permit.
Release Date: 5-15-19
Review Date: 5/22
Termination Date:

This activity is designated for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM.
03/21/2019
Shahab Mahboubian, Other.
Presenter
Hope Conference Center
Diagnosis and Management of Rheumatoid Arthritis
TUESDAY, March 19, 2019
12:15pm—Hope Conference Center
DIAGNOSIS AND MANAGEMENT OF RHEUMATOID ARTHRITIS
PENG FAN, MD
CLINICAL PROFESSOR OF MEDICINE, DIVISION OF RHEUMATOLOGY
DAVID GEFFEN SCHOOL OF MEDICINE AT UCLA
PLANNER/MODERATOR:
Nilesh Desai, MD, Department of Medicine liaison to the Medical Education Committee, PSJMC
FACULTY/PLANNER DISCLOSURES:
It is our policy to ensure that planners, faculty and content are independent of commercial bias. Dr. Desai states he has no financial arrangements with any commercial company to disclose. Dr. Fan discloses he is on the Speakers Bureau for Amgen, Novartis, Pfizer, Sanofi, Genzyme, Abbrie, Radius, Regeneron. It is our policy to review presentations ahead of time in order to resolve any potential conflicts of interest. No conflicts were identified in the review of today’s presentation.
Disclosures for members of the Medical Education Committee may be found at the CME sign-in desk and on the CME website at
www.providencecme.org.
Click Here For Learning Objectives
Release Date: 5-15-19
Review Date: 5/22
Termination Date:

This activity is designated for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM.
03/19/2019
Peng Fan
Presenter
Hope Conference Center
Recognition and Management of Osteoarthritis
THURSDAY, March 14, 2019
12:15pm, Hope Conference Center
RECOGNITION AND MANAGEMENT OF OSTEOARTHRITIS
PENG FAN, MD
CLINICAL PROFESSOR OF MEDICINE, DIVISION OF RHEUMATOLOGY
DAVID GEFFEN SCHOOL OF MEDICINE AT UCLA
PLANNER/MODERATOR:
Nilesh Desai, MD, Department of Medicine liaison to the Medical Education Committee, PSJMC
FACULTY/PLANNER DISCLOSURES:
It is our policy to ensure that planners, faculty and content are independent of commercial bias. Dr. Desai states he has no financial relationship with a commercial company to disclose. Dr. Fan discloses he is on the Speakers Bureau for Amgen, Novartis, Pfizer, Sanofi, Genzyme, Abbrie, Radius, Regeneron. It is our policy to review presentations ahead of time in order to resolve any potential conflicts of interest. No conflicts were identified in the review of today’s presentation.
Disclosures for members of the Medical Education Committee may be found at the CME sign-in desk and on the CME website at
www.providencecme.org.
Click Here For Learning Objectives

This activity satisfies DHS radiology requirements for renewal of fluoroscopy permit.
Release Date: 5-15-19
Review Date: 5/22
Termination Date:

This activity is designated for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM.
03/14/2019
Peng Fan, MD.
Presenter
Hope Conference Center
Heart Failure: When to Consider Bridge Devices or Transplantation
TUESDAY, February 26, 2019
HEART FAILURE: WHEN TO CONSIDER BRIDGE DEVICES OR TRANSPLANTATION JON KOBASHIGAWA, MD
DSL/THOMAS D. GORDON CHAIR IN HEART TRANSPLANTATION MEDICINE
CEDARS-SINAI MEDICAL CENTER
PLANNER/MODERATOR:
Daniel Eisenberg, MD, Medical Director, Cardiac Services, PSJMC
FACULTY/PLANNER DISCLOSURES:
It is our policy to ensure that planners, faculty and content are independent of commercial bias. Dr. Eisenberg states he has no financial arrangements with any commercial company to disclose. Dr. Kobashigawa states he has received consulting fees from CareDX and research grants from CareDX, Novartis, and Sanofi/Genzyme. It is our policy to review presentations ahead of time in order to resolve any potential conflicts of interest. No conflicts were identified in the review of today’s presentation.
Disclosures for members of the Medical Education Committee may be found at the CME sign-in desk and on the CME website at
www.providencecme.org.
Click Here For Learning Objectives
Release Date: 4-12-19
Review Date: 4/22
Termination Date:

This activity is designated for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM.
02/26/2019
Jon Kobashigawa, MD.
Presenter
Hope Conference Center
 
© Providence Health & Services | Organized Health Care Arrangement | Disclaimer | Contact Us | About Us